Dr. Bruce Kerwin

Dr. Kerwin has worked in the biotechnology industry for 30 years and is a recognized expert in protein formulation and drug product development. Dr. Kerwin worked for multiple companies including Baxter Hemoglobin Therapeutics, Amgen, Just-Evotec Biologics and Umoja Biopharma before joining the Scientific Advisory Board of Coriolis. Dr. Kerwin led numerous scientific research and project teams developing novel solutions to formulation problems such as high viscosity, high concentration, protein co-formulation while successfully bringing drug candidates through development from pre-IND to commercialization. His work on large and small volume parenterals included recombinant hemoglobin, cytokines, monoclonal antibodies, antibody drug conjugates, PEGylated proteins, glycosylated and non-glycosylated proteins, oncolytic viruses and lentivirus. Dr. Kerwin was also intimately involved with alternative drug delivery systems such as slow release and nanoparticle formulations. His research has yielded over 60 research publications and book chapters in a wide array of areas relating to protein science and formulation development, including protein stabilization, polysorbate degradation, photodegradation, protein phosphorescence, and high throughput biophysical screening. Dr. Kerwin is an inventor on multiple patents and is a member of the editorial advisory board for the Journal of Pharmaceutical Science.

Bruce Kerwin